A controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile seizures.
BACKGROUND
Phenobarbital, once widely prescribed to prevent febrile seizures, is now in disfavor because of its side effects and lack of efficacy. Diazepam, administered only during episodes of fever, may be a safe, effective agent to prevent the recurrence of febrile seizures.


METHODS
We conducted a randomized, double-blind, placebo-controlled trial among 406 children (mean age, 24 months) who had at least one febrile seizure. Diazepam (0.33 mg per kilogram of body weight) or placebo was administered orally every eight hours during all febrile illnesses.


RESULTS
During a mean follow-up of 1.9 years (a period during which 90 percent of febrile seizures recur), our intention-to-treat analysis showed a reduction of 44 percent in the risk of febrile seizures per person-year with diazepam (relative risk = 0.56; 95 percent confidence interval, 0.38 to 0.81; P = 0.002). A survival analysis of the length of time to the first recurrent febrile seizure did not show a significant difference between the treatment groups (P = 0.064 by the log-rank test), but after adjustment for covariates, diazepam was found to have a benefit (P = 0.027 by Cox regression analysis). An analysis restricted to children who had seizures while actually receiving the study medication (7 in the diazepam group and 29 in the placebo group) showed an 82 percent reduction in the risk of febrile seizures with diazepam (relative risk = 0.18; 95 percent confidence interval, 0.09 to 0.37; P < 0.001). Of the 153 children who took at least one dose of diazepam, 39 percent had ataxia, lethargy, or irritability or at least one other moderate side effect that was reversed after a reduction in the dose. There were no severe side effects.


CONCLUSIONS
Oral diazepam, given only when fever is present, is safe and reduces the risk of recurrent febrile seizures.
Rosman
N P
NP
Department of Pediatrics, Tufts University School of Medicine, Boston, MA.
Colton
T
T
Labazzo
J
J
Gilbert
P L
PL
Gardella
N B
NB
Kaye
E M
EM
Van Bennekom
C
C
Winter
M R
MR
D000284:Administration, Oral; D002675:Child, Preschool; D003975:Diazepam / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D005334:Fever / Q000503:physiopathology; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008297:Male; D010349:Patient Compliance; D010352:Patient Dropouts; D016016:Proportional Hazards Models; D012008:Recurrence; D003294:Seizures, Febrile / Q000209:etiology / Q000517:prevention & control*; D016019:Survival Analysis; D016896:Treatment Outcome
D003975:Diazepam